Organon India to Co-Market Its Contraceptive Pills With GSK

Organon India has established a co-marketing arrangement with GlaxoSmithKline Pharmaceuticals India for two of its oral contraceptive pills -- Femilon and Cerazette. This arrangement is valid for a period of 10 years. Organon worldwide has been an innovator and leading player in the field of contraception for over three decades. In India, Organon has a significant market share in the oral contraceptive segment. With this arrangement, Organon India seeks to further develop the contraceptive market, the release stated here.

Pharmabiz (http://www.pharmabiz.com/article/detnews.asp?articleid=27446§ionid=)